Gulf Pharmaceutical Industries Julphar reduced its losses in the first quarter of 2020 to 68.9 million dirhams, compared to 91.6 million dirhams in the first quarter of 2019.
According to Al Bayan newspaper, the company recorded accumulated losses of about 565.7 million dirhams at the end of the first quarter of this year, equivalent to 49% of the capital.
The company stated that it had taken several measures to address the losses, including lifting the temporary suspension on each of Saudi Arabia, Bahrain and the Sultanate of Oman, and the temporary suspension of Kuwait is expected to be lifted soon, along with the launch of products. New options to increase market share and improve profitability.
